 |
|
Herbs as Medicines
Lisa Corbin Winslow, MD;
David J. Kroll, PhD
Arch Intern Med. 1998;158:2192-2199.
ABSTRACT
Herbs and related products are commonly used by patients who also seek conventional health care. All physicians, regardless of specialty or interest, care for patients who use products that are neither prescribed nor recommended. Some herbs have been extensively studied, but little is known about others. When a patient asks for advice regarding the use of a particular herb, how should a physician respond? Similarly, how does a physician determine if a patient's symptoms are caused by a "remedy"? This review attempts to answer these questions by investigating pertinent definitions, the history of herbs in medicine, epidemiology and prevalence of herbal use, and relevant psychosocial issues.
INTRODUCTION
While a complete review of specific herbs is impossible in this setting (>20,000 herbal and related products are used in the United States),1 the potential benefits and hazards of some of the more popular herbal products in use are examined (Table 1).
|
|
|
|
Table 1. Definitions of Terms Used in This Article
|
|
|
HISTORY
The earliest evidence of humans' use of plants for healing dates back to the Neanderthal period.3 In the 16th century, botanical gardens were created to grow medicinal plants for medical schools.4 Herbal medicine practice flourished until the 17th century when more "scientific" pharmacological remedies were favored.5
In the United States, the history of herbal use begins in the early colonial days when health care was provided by women in the home. Initially, they used homemade botanical remedies and later purchased similar products as "patent medicines." In the early 19th century, scientific methods became more advanced and preferred, and the practice of botanical healing was dismissed as quackery. In the 1960s, with concerns over the iatrogenic effects of conventional medicine and desire for more self-reliance, interest in "natural health" and the use of herbal products increased.5 Recognition of the rising use of herbal medicines and other nontraditional remedies led to the establishment of the Office of Alternative Medicine by the National Institutes of Health (Bethesda, Md) in 1992. Worldwide, herbal use again became popular; in 1974 the World Health Organization (Geneva, Switzerland) encouraged developing countries to use traditional plant medicines to "fulfill a need unmet by modern systems."5
Thirty percent of all modern drugs are derived from plants.3 Some of the more familiar ones are listed in Table 2.4, 6-7
|
|
|
|
Table 2. Conventional Medicines Derived From Plants
|
|
|
EPIDEMIOLOGY
Estimates of the prevalence of herbal medicine use differ, with studies concluding that between 3% and 93% of the US population uses herbs (Table 3).7-10 The variability of these estimates is due to discrepant definitions of herbs (Table 1) as well as different inclusions of the length of use (ie, ever vs in the last 12 months).
|
|
|
|
Table 3. Representative Epidemiological Studies of Herbal Medicine Use*
|
|
|
Internationally, the use of botanical medicines is generally higher. For example, 70% of "Western" doctors in Japan prescribe kampo drugs daily.11 Eighty percent of the world's population relies primarily on traditional medicines for their health care needs.5, 12 It is certain that physicians are seeing patients who are using herbs, and, as is discussed, this use can affect the patient's health problems and effects of conventional treatments.
ECONOMICS AND REIMBURSEMENT
The amount of money spent on herbal remedies is significant. Americans spent $553 million in 8000 health food stores in 1994,13 and from all sources, the estimate of US "medical" herb sales is $1.2 billion in 1996.14 Sales of herbal medicines are growing by 20% a year, and herbs are the largest growth area in retail pharmacy, far exceeding growth in the conventional drug category.15
Costs to the individual and costs of individual products can also be substantial, albeit variable. An epidemiological study10 of patients positive for human immunodeficiency virus found that the average herbal user was spending $18 per month on herbs (range, $0-$175). Individual products have variable costs, dependent on both the product and its source (homegrown, imported, from a health food store, or from an herbalist). In another study16 of herb use among patients with the acquired immunodeficiency syndrome (AIDS), one product recommended by a health food store sold for almost $150 for a month's supply.
Insurance plans and managed care organizations are beginning to offer reimbursement for alternative treatments. In fact, coverage of chiropractic treatment is mandated by law in at least 45 states, acupuncture in 7 states, and naturopathy in 2 states.17 Insurance plans that cover alternative health care often require physician referral for these services, highlighting the importance of physician awareness. One managed care company, Oxford Health Plans, Norwalk, Conn, is planning to cover alternative treatments, including some that use herbal remedies, basing their decision on a survey showing that 33% of its 1.5 million members had sought alternative treatment in the last 2 years. American Western Life Insurance Company, San Mateo, Calif, has a "prevention plus" plan that covers herbal medicines. Industry analysts expect many other insurance plans to follow suit to compete for this untapped multibillion dollar market.17 Although reimbursement for herbal medicines is in its infancy, it is expected to grow tremendously along with the continued boom in sales of herbal products and alternative health care in general. In Germany, herbs prescribed by physicians are covered by insurance, whereas over-the-counter herbs are not; and German physicians are much more knowledgeable about their use.14 Physicians must become familiar with herbal medicine, as more insurance companies will expect their physicians to make referrals or suggest herbal products.
WHY DO PEOPLE USE HERBAL MEDICINES?
There are multiple reasons patients turn to herbal therapies. Often cited is a "sense of control, a mental comfort from taking action,"9 which helps explain why many people taking herbs have diseases that are chronic or incurable, such as diabetes, cancer, arthritis, or AIDS. In such situations, they often believe that conventional medicine has failed them. When patients use home remedies for acute, often self-limited conditions, such as a cold, sore throat, or bee sting, it is often because professional care is not immediately available, too inconvenient, costly, or time consuming.9, 18
In rural areas, there are additional cultural factors that encourage the use of botanicals, such as the concept of an interplay between the environment and culture, a "man-earth" relationship.12 Religious beliefs, which can be traced to the medieval doctrine of signatures, are also prominent: "The good Lord has put these yerbs here for man to make hisself with. They is a yerb, could we but find it, to cure every illness [sic]."19 People believe that where an area gives rise to a particular disease, it will also support plants that can be used to cure it.5
Natural plant products are perceived to be healthier than manufactured medicines.12 Additionally, reports of adverse effects of conventional medications are found in the lay press at a much higher rate than reports of herbal toxicities, in part because mechanisms to track adverse effects exist for conventional medicines whereas such data for self-treatment is harder to ascertain. Even physicians often dismiss herbs as harmless placebos,10 and many consumers and physicians alike mistakenly believe that anything in a pill form has been approved by the US Food and Drug Administration (FDA).1
REGULATION: DIETARY SUPPLEMENT AND HEALTH EDUCATION ACT
In 1993, the FDA began scrutinizing the herbal and supplement industry, which triggered a massive letter-writing campaign organized by health food stores that encouraged consumers to "write your congressman or kiss your supplements goodbye." Under pressure, the FDA compromised its plans, creating the supplement category, which includes vitamins, minerals, and herbs and created the Dietary Supplement and Health Education Act (DSHEA) signed October 1994. The DSHEA requires no proof of efficacy, no proof of safety, and sets no standards for quality control for products labeled as supplements. Although the DSHEA requires that supplements not promise a specific cure on the label, they may claim effect. Now, if questions arise, the burden lies with the FDA to prove a product unsafe, rather than a company proving its product safe. Manufacturers must put a message on the label stating that claims have not been reviewed by the FDA, but this statement can be subtle.1 In contrast, regulating agencies in Germany, France, the United Kingdom, and Canada enforce standards of herb quality and safety assessment on manufacturers.20-21
Because of the lack of requirements for quality control, safety, and efficacy, consumers cannot determine if an herb's active ingredients are actually in the product, if the ingredient is bioavailable, if the dosage is appropriate, if the next bottle they buy will have the same components, or what else is in the pill besides the claimed ingredients.1
QUALITY CONTROL
Any particular herb or mixture can vary from manufacturer to manufacturer and from batch to batch; an herb that is not toxic or therapeutic in one form or strength may be helpful or harmful in a different preparation.
Potency of various compounds is affected by growing conditions, storage, handling, and preparation such that potency of various products from the same plant can vary 10,000-fold.1 Manufacturers use varying methods for processing the same herbs; for example, the plant can be ground up and put into pill form, or pharmaceutical methods can be used to extract the desired compound, assay the composition, and make tablets of consistent strength.1
Consumer Reports1 looked at the composition of 10 different ginseng products on the market in 1995. The amount of ginseng per tablet was listed on the labels, but the amount of ginsenosides, thought to be the active components, was not listed. They found striking differences between the products (Figure 1), which could have an impact if a patient changed from one brand to another, especially as ginseng does have dose-dependent adverse effects.
|
|
|
|
Consumer Reports1 analyzed 10 popular brands of ginseng and found the amount of ginsenosides (black bar) was widely variable in each brand. The amount of ginseng (white bar) were listed on the packages, but ginsenoside content (active ingredient) was not. Reprinted with permission from Consumer Reports.
|
|
|
Labels may be incorrect, accidentally or intentionally. The same common name may be applied to different plants recommended for different illnesses.22 Some products labeled as ginseng actually also contain mandrake (scopolamine) or snakeroot (reserpine) because of the high cost of pure ginseng.23 Additives may be used, yet not listed on labels; they may be the source of the therapeutic effect. Examples include steroids, nonsteroidal anti-inflammatory agents, prescription antibiotics, sedatives, and narcotics.1, 24-26
Herbs can be misidentified or the wrong part of the plant may be picked. Such an error was the cause of an outbreak of belladonna poisoning attributable to an herbal tea in New York City,1 and a similar misidentification led to digitalis poisoning from a mislabeled plantain extract.27
Heavy metals are often found in herbal preparations from other countries as they are thought to help cure without being absorbable. However, there are multiple reports in the literature of poisoning with lead, arsenic, cadmium, copper, and mercury found in herbal preparations from foreign countries.28-34 Also problematic with herbs imported from foreign sources is that written instructions, if any, are often in foreign languages.32
EFFICACY AND SAFETY STUDIES
Controlled studies of herbal medicines are not profitable. There is little motivation for manufacturers to conduct randomized, placebo-controlled, double-blinded clinical trials to prove efficacy because (1) they are not required to do so and (2) they cannot patent the product to recoup the estimated $350 million it costs to prove a new drug effective and safe.13 An entirely new drug must be created, or a novel extraction procedure or pharmaceutical dosage form must be discovered as a result of undertaking the study to produce patentable and thus profitable studies.
Despite these limitations, some scientific studies are being performed. Such studies often originate in other countries where the funding constraints are not as problematic, and where regulatory authorities require some basic assessment of safety and efficacy.
With the resultant lack of solid scientific analysis in the United States, claims for benefits are thus mainly supported solely with anecdotal case reports that fail to consider the natural history of the disease or the placebo effect. Toxic effects, if any, are seldom reported.
TOXICITIES
It is important to acknowledge that all conventional drugs have potential toxicities. However, in contrast to herbal products, conventional drugs undergo trials and postapproval surveillance that define these toxicities, giving practitioners data on that to weigh risks and benefits of treatment. The therapeutic window and dosage are also defined, as are the constituents of the medicine. Because of rigorous quality control, each pill has the same ingredients as another. Adverse reactions to herbal medicines are probably underrecognized and underreported.35
Physicians should become familiar with some of the more common herbal toxicities to determine if an herb is causing a patient's problems; the easiest way is to keep a shelf reference in the office.21, 36-37 Additionally, one can seek case reports in the literature, send the remedy in question to a laboratory (at university hospital settings, call the toxicology laboratory) that can analyze a particular herb for its constituents and possible contaminants, or consult Poisindex (a list of plants considered unsafe by the FDA is available). The FDA also posts recent warnings on herbal products on their Internet page (http://www.fda.gov). With mild toxicities, such as gastrointestinal upset or mildly elevated values on liver function tests, the physician can try stopping the herbal treatment and see if the problem resolves and consider a rechallenge for recurrence.
Table 4 outlines toxicities of some of the more popular herbs, listed by organ system.
|
|
|
|
Table 4. Reported Adverse Effects of Some Common Herbs*
|
|
|
There has been little evaluation of interactions between regulated drugs and herbs, but knowledge of some adverse reactions (and therapeutic actions) of herbal medicines can help one predict drug interactions. For example, herbs containing cardiac glycosides may potentiate effects of digoxin; herbs with diuretic effects may potentiate digoxin toxicity via potassium loss. Herbs that can cause hypertension or hypotension can interfere with prescription antihypertensive agents; hypoglycemic herbs can interfere with glycemic control in a patient with diabetes. Some herbs interfere with prescription medications by altering their metabolism. For example, Eucalyptus can induce microsomal liver enzymes51 while flavonoids from Echinacea purpurea are known to inhibit the cytochrome P-4503A4 and sulfotransferase drug-metabolizing enzymes.52-53
Not only might herbal therapy be toxic, but using an herbal remedy over a proven conventional therapy can be dangerous, too. Many oncologists have seen patients with early-stage cancers who eschewed curative conventional care in favor of herbal medicines. After these herbal treatments failed, the patients returned to the oncologists with incurable metastatic diseases. In fact, studies54 have shown that patients who use herbs and other alternative therapies are more likely to abandon potentially beneficial conventional therapy when faced with an illness. Patients may also continue detrimental behaviors, such as smoking tobacco or drinking large amounts of alcohol, with the rationalization that the herbal remedy they are taking will be protective.
An herb that may be safe in small doses may become dangerous in higher doses. The risk of overdose is higher in herbal preparations than conventional medicines because of the already mentioned product variability. Consider the patient who assumed if "some is good, more is better" with respect to a copper-containing supplement he was taking. As he began to feel worse, he increased the dose. By the time he came to the attention of conventional health providers, he was unable to eat and was wasted and jaundiced, and had acquired Wilson disease.13 Patients may assume herbs such as garlic and nutmeg to be safe, as they are commonly used in cooking without adverse effect. However, herbs in extract form are often much more potent than the traditionally used form, and can be harmful (Table 3).
COMMONLY USED HERBS
Of the 20,000 available products, which is the physician most likely to encounter? A 1995 survey of 163 US health food retail stores revealed that the top 10 selling herbs were echinacea (Echinacea purpurea and angustifolia), garlic (Allium sativum), goldenseal (Hydrastis canadensis), ginseng (Asian Panax ginseng and American Panax quinquefolius), ginkgo (Ginkgo biloba), saw palmetto (Serenoa repens), aloe (Aloe species), ma huang (Ephedra sinica), Siberian ginseng (Eleutherococcus senticosus), and cranberry (Vaccinium macrocarpon).55 More recent trends suggest that St John's wort (Hypericum perforatum), valerian (Valeriana officinalis), and feverfew (Tanacetum parthenium) will likely earn a top 10 designation when 1998 data become available.
Patients decide which herbs to use in a variety of ways. Because of the requirements that herbal medicines must not directly claim cures on the label, manufacturers have become creative with marketing. Products are given names that allude to their effects, such as "Insomnia," "PMS," "Sleep," and "Get Trim." Pamphlets, books, and other advocacy literature not subject to labeling guidelines are shelved near herbs. Patients also get information through word of mouth, encouraged by anecdotal reports from friends. An herbalist who has training in the use of plants for healing may be consulted.
Advice can be found from health food store workers. An undercover 1993 FDA study asked clerks what to buy "for my immune system," "high blood pressure," or "something that works on cancer." From 129 clerks surveyed, 120 specific and highly variable recommendations were received.1 Phillips et al,16 in 1995, surveyed 20 Birmingham, Ala, area health food stores for their recommendations for AIDS. Combination products (with names like "Immunace," "Immunaction," or "Immunectar") were most frequently recommended; ginseng-containing products were recommended second (and were the most expensive). Pharmacists, on the other hand, are unlikely to give specific recommendations on herbal products sold in their stores, and say they do not know much about them.1 In fact, only 5% of the US herbal market is actually sold in pharmacies.20
People can also explore the Internet to discover information about herbs. Internet sources are often perceived as "published" and therefore entirely factual. However, most sites merely list herbs and their uses, few mention regulations, safety, or efficacy. Even an herb with well-recognized toxicities, such as ephedra, may have no cautionary statement. A few sample Web sites are listed below:
- FDA: Access to "MEDWATCH," with herb warnings under "special nutritionals adverse event monitoring system" link. Available at: http://www.fda.gov. The direct address to the searchable database is http://www.vmcfsan.fda.gov/~dms/aems.html.
- ASPET Herbal and Medicinal Plant Interest Group: A site for an herb discussion group among classic pharmacologists; also with some interesting links. Available at: http://www.faseb.org/aspet/H&MIG3.htm#top.
- American Botanical Council: A respected organization dedicated to dissemination of factual herbal information. Herb Research Foundation: A nonprofit organization supported by the American Botanical Council. Available at: http://www.herbs.org.
- Botanical.com: Contains the 1931 text "A Modern Herbal," also the "Ask Dr Weil" column, who integrates Western medicine and herbs: somewhat biased toward herbs; however, with emphasis on anecdotes. Available at: http://www.botanical.com.
- Herbal Information Center: Brief overviews on common herbs; few warnings; mostly geared to sell. Available at: http://www.kcweb.com/herb/herbmain.htm.
- HerbNet: Links to other herb sites; mostly advertisements but some good information can be found. Available at: http://www.herbnet.com.
- Herbal Resource Inc: Primarily a sales site but occasionally references are noted. Biased and misleading, even stating that "there are no side effects from herbs." Available at: http://www.herbsinfo.com.
- University of Washington Medicinal Herb Garden: Nice pictures of herbs; cross-reference to MEDLINE abstracts, excellent resource. Available at: http://www.nnlm.nlm.nih.gov/pnr/uwmhg/.
When patients or practitioners want nonbiased information on a commonly used herb, they are advised to buy a book that bases advice on published and critically reviewed literature. A comprehensive literature search will ensure the most scientific, peer-reviewed information is being reviewed, but this process is often time consuming and, thus, impractical. Beginning in 1978, the German equivalent of the FDA went as far as to publish a series of herb recommendations, the Commission E Monographs, which detail dosages and indications for herbs whose efficacy is supported by the literature, and these have recently become available in the United States. However, the extrapolation of these European findings (usually conducted with well-characterized, pharmaceutical herbal preparations) to herbs available in the United States is complicated by the relative lack of regulatory standards in this country, as described earlier.
The great variation in US herb quality is unfortunate in light of the known pharmacological actions in humans of well-characterized botanical preparations. If one can put the question of US regulation aside, comments can thus be made on the efficacy of some of the best-selling herbs mentioned above.
Valerian (Valeriana officinalis) ranks as one of the most well characterized of the widely used herbs. Listed in The National Formulary until 1950, valerian has been described in human studies as possessing sedative and anxiolytic activity56 and is often combined with other sedative herbs like hops (Humulus lupulus).
In the case of Ginkgo biloba, which contains ginkgolides that antagonize platelet-activating factor, human studies were greatly facilitated by the availability of a high-quality extract (EGb 761) from the manufacturer, Willmar Schwabe, in Karlsrube, Germany. The efficacy of Ginkgo biloba extract in improving or delaying cognitive deficits was recently demonstrated in a multicenter US trial of 309 patients with early-stage Alzheimer dementia. Improvements in 2 of 3 clinical parameters of cognitive function were observed as early as at 12 weeks of Ginkgo extract, Egb 761, when compared with placebo.57 Understandably, Ginkgo should be used with care in this population due to the prevalence of prescription anticoagulant therapy.
Ginseng is another widely used herb touted in Chinese traditional medicine as an "adaptogen" that allows the body to respond to physical and emotional stress. The best data to date support a role for ginseng as a vasodilator and in serving a cardioprotective role in the presence of oxygen free radicals.58 The mechanism of these effects is likely due to certain ginsenosides present in Panax ginseng that appear to stimulate nitric oxide synthase and increase nitric oxide production and release.
For the practicing internist, the most interesting data come from efficacy comparisons between herbs and prescription medications. For example, limited data suggest that saw palmetto compares favorably with finasteride in the management of benign prostatic hyperplasia.59 In treating mood disorders, St John's wort has been shown to be equally efficacious to the older, tricyclic antidepressants.60 However, it should be stressed that these studies were performed with highly characterized botanical preparations under the guidance of trained physicians. The wisdom of herbal self-treatment, as is often the case in the United States, is discussed in the following section, along with more information about specific herbs the internist is likely to encounter.
PHARMACOLOGICAL BASIS FOR USE OR AVOIDANCE OF HERBAL MEDICINES
Given the previously detailed shortcomings of herbal preparations in the United States, the question arises whether any herbs possess pharmacological activity distinct from prescription or over-the-counter drugs that might therefore warrant their cautious use. Such herbs are few. The most commonly used herb in the United States and Europe, Echinacea purpurea, may be one. Unlike over-the-counter decongestants or antihistamines, alkylamide and polysaccharide constituents of echinacea possess significant in vitro and in vivo immunostimulation due to enhanced phagocytosis and nonspecific T-cell stimulation.61 However, to our knowledge, only a few clinical trials have been done with echinacea, and only a handful were well designed. One well-designed, double-blind study randomized 100 patients with acute flulike illness to an echinacea extract or placebo and showed that echinacea decreased the duration of symptoms from 10 to 7 days. Another study, with 647 students from the University of Cologne given echinacea or placebo prophylactically during flu season, showed a 15% reduction in the number of colds in the group given echinecea. Neither study used commonly available preparations of echinacea.37
Most herbs fall into the category of agents that share pharmacological mechanisms of action with already existing prescription or over-the-counter drugs. Based on a logical consideration of the current state of herb standardization and pharmacokinetic evaluation, the patient would be best steered toward a regulated pharmaceutical preparation capable of a predictable pharmacological response. For example, powdered ginger root has been tested in humans for prophylaxis against motion sickness compared with dimenhydrate (Dramamine).62 While one study63 reported 1.8 mg of ginger superior to 100 mg of dimenhydrate, a follow-up study failed to show any efficacy of ginger. Other examples of herbs possessing actions similar to existing, regulated drugs are feverfew for migraines,64 valerian for anxiety,65 and garlic for hypercholesterolemia.66
Of greater concern to the physician is when patients use herbs with redundant pharmacological activity for diseases not recommended for self-treatment. Miller67 heightened the public's awareness of the antidepressant actions of St John's wort, an herb containing the potential monoamine oxidase inhibitor hypericin. While St John's wort has shown promising antidepressant action,60 it is unlikely that patients can make a diagnosis of endogenous depression, much less differentiate their condition from medical conditions mimicking depression. In addition, there remains concern for hypertensive reactions resulting from concomitant ingestion of high tyramine-containing foods and St John's wort, and hypericin is well known to cause photosensitivity.68 With St John's wort, the question is not whether the herb has therapeutic efficacy but rather issues of safety and appropriateness of the disease as a candidate for self-treatment.
Similarly, the use of saw palmetto for benign prostatic hypertrophy presents another dilemma. While hydrophobic extracts of Serenoa repens berries indeed possess 5 -reductase inhibitory and androgen receptor antagonistic activities in vitro,69 it is unwise for men to self-diagnose benign prostatic hypertrophy, with the clear risk of potentiating the growth of undiagnosed prostatic carcinoma.
CONCLUSIONS
Herbal remedies are commonly used by patients who access conventional health care. Few have been shown to have beneficial effects beyond those of conventionally regulated products, and they may be costly, adulterated with dangerous additives, inherently toxic, or cause the patient to forgo potentially curative care.
All medicines can be toxic under specific circumstances; there is always a risk that an adverse reaction will present a hazard to a patient. With licensed medicines, however, regulations ensure the risk is small and monitor the medicine's efficacy, safety, and quality. No such controls over herbal medicines exist.36 As stated by Brown and Marcy,9 the hazards of self-treatment are no less serious because of the presence of similar hazards in conventional medicine.
If a patient presents with a problem that might be due to an herb, the physician should discontinue the product and watch for resolution. Reference books, Poisindex, or MEDLINE should be consulted to see if such an adverse reaction has been described. The FDA has implemented MEDWATCH, a toll-free number to which adverse effects of herbs can be reported (1-800-332-1088).70 If necessary, herbs can be sent to laboratories for content analysis, either to a toxicology laboratory or a pharmacology department. Botany departments at major universities can also be a source of information.
If patients ask if "herbal medicines" in general are safe or effective, they should be counseled about the lack of regulations for quality, safety, or efficacy, the differences in preparations from different manufacturers, and the lack of mechanism for reporting adverse effects. Curious patients can be directed to read the books mentioned, and cautioned against biased information that they may receive from health food store employees, pamphlets shelved near herbs, and the Internet.
If patients mention a friend who was helped by a certain remedy or an advertisement that was seen depicting a dramatic success with a certain herb, they should be counseled on the dangers of anecdotal reports. Patients take our recommendations of conventional medicines because we suggest it, not because we present them with reams of data from randomized controlled trials; thus, it is not unexpected that their approach to the use of unconventional medicine is the same.
Patients with chronic conditions such as AIDS or cancer should also be warned that some of the adverse effects of herbals are often similar to symptoms of problems associated with their disease or treatment, thus making it difficult to discern if the disease or the "remedy" is the problem.
Classically trained physicians cannot ignore herbal medicines anymore. We must realize that patients are using herbal medicines, and insurance companies are beginning to cover the costs and are even asking us to oversee the use of herbs in certain situations. We must all become educated about these products, and at the very least know where to find information when we need it.
Asking patients about supplement use during the initial history is thus imperative. Patient disclosure of herb use may provide an opportunity for the physician to redirect the patient toward effective conventional health care. By taking a complete drug and supplement history, a dialogue can be initiated to rationally compare the appropriateness of herbal remedies and regulated pharmaceuticals in relation to the severity of the condition. Until herbs in this country are more strictly regulated, however, no classically trained physician should recommend an herbal product to a patient. For the herb-using patient who views conventional medicine with ambivalence, the physician can foster a more open and communicative relationship by demonstrating an objective understanding of both alternative and conventional approaches.
AUTHOR INFORMATION
Accepted for publication November 20, 1997.
Reprints: Lisa Corbin Winslow, MD, HealthONE Center for Health Sciences Education, 1719 E 19th Ave, 5C-East, Denver, CO 80218.
From the HealthONE Center for Health Sciences Education (Dr Winslow), the Division of General Internal Medicine (Dr Winslow), and the School of Pharmacy (Dr Kroll), University of Colorado Health Sciences Center, Denver.
REFERENCES
| |
1. Herbal roulette. Consumer Reports. November 1995:698-705.
2. The American College Dictionary. New York, NY: Random House Inc; 1957:565.
3. Kleiner SM. The true nature of herbs. Phys Sports Med. 1995;23:13-14.
4. Akerele O. Nature's medicinal bounty: don't throw it away. World Health Forum. 1993;14:390-395.
PUBMED
5. Trevelyan J. Herbal medicine. Nurs Times. 1993;89:36-38.
6. Aliotta G, Capasso G, Pollio A, Strumia S, De Santo NG. Early contributors to nephrology: Joseph Jacob Plenck. Am J Nephrol. 1994;14:377-382.
ISI
| PUBMED
7. Frate DA, Croom EM, Frate JB, Juergens JB. Self-treatment with herbal and other plant-derived remedies: rural Mississippi, 1993. MMWR Morb Mortal Wkly Rep. 1995;44:204-207.
PUBMED
8. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. N Engl J Med. 1993;328:246-252.
FREE FULL TEXT
9. Brown JS, Marcy SA. The use of botanicals for health purposes by members of a prepaid health plan. Res Nurs Health. 1991;14:339-350.
ISI
| PUBMED
10. Kassler WJ, Blanc P, Greenblatt R. The use of medicinal herbs by human immunodeficiency virus-infected patients. Arch Intern Med. 1991;151:2281-2288.
FREE FULL TEXT
11. Ross C. New life for old medicine. Lancet. 1992;342:486-487.
FULL TEXT
12. Gesler WM. Therapeutic landscapes: medicinal issues in light of the new cultural geography. Soc Sci Med. 1992;34:735-746.
13. Marwick C. Growing use of medicinal botanicals forces assessment by drug regulators. JAMA. 1995;273:607-609.
FREE FULL TEXT
14. Tyler VE. What pharmacists should know about herbal remedies. J Am Pharm Assoc. 1996;36:29-37.
15. The right stuff: Drug Store News picks the categories taking off in ‘94. Drug Store News. 1994;16:15.
16. Phillips LG, Nichols MH, King WD. Herbs and HIV: the health food industry's answer. South Med J. 1995;88:911-913.
FULL TEXT
|
ISI
| PUBMED
17. Whitaker B. Now in the HMO: yoga teachers and naturopaths. New York Times. November 24, 1996:11.
18. Gill GV, Redmond S, Garratt F, Paisey R. Diabetes and alternative medicine: cause for concern. Diabet Med. 1994;11:210-213.
ISI
| PUBMED
19. Price E. Root digging in the Appalachians: the geography of botanical drugs. Geogr Rev. 1960;50:1-20.
FULL TEXT
20. Tyler VE. Herbs of Choice: The Therapeutic Use of Phytomedicinals. Binghampton, NY: Pharmaceutical Products Press; 1994.
21. Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals. London, England: The Pharmaceutical Press; 1996.
22. Saxe T. Toxicity of medicinal herbal preparations. Am Fam Physician. 1987;35:135-142.
23. Siegel R. Kola, ginseng, and mislabeled herbs. JAMA. 1978;237:24.
24. Abt AB, Oh JY, Huntington RA, Burkhart KK. Chinese herbal medicines induced acute renal failure. Arch Intern Med. 1995;155:211-212.
FREE FULL TEXT
25. DuPont R, Bogema S. Benzodiazapines in a health-catalog product. JAMA. 1990;264:695.
26. Capobianco DJ, Brazis PW, Fox TP. Proximal-muscle weakness induced by herbs. N Engl J Med. 1993;329:1430.
FREE FULL TEXT
27. The Denver Post. June 13, 1997.
28. Holtan N, Hall S, Knight F, et al. Nonfatal arsenic poisoning in three Hmong patients: Minnesota. MMWR Morb Mortal Wkly Rep. 1984;33:347-349.
PUBMED
29. Levitt C, Paulson D, Duvall K, et al. Folk remedy associated lead poisoning in Hmong children: Minnesota. MMWR Morb Mortal Wkly Rep. 1988;32:555-556.
30. Smitherman J, Harber P. A case of mistaken identity: herbal medicine as a cause of lead toxicity. Am J Ind Med. 1991;20:795-798.
ISI
| PUBMED
31. Markowitz SB, Nunez CM, Klitzman S, et al. Lead poisoning due to Hae Ge Fen: the porphyrin content of individual erythrocytes. JAMA. 1994;271:932-934.
FREE FULL TEXT
32. Shaw D, House I, Kolev S, Murray V. Should herbal medicines be licensed? BMJ. 1995;11:451-452.
33. Baker D, Brender J, Davis K. Cadmium and lead exposure associated with pharmaceuticals imported from Asia: Texas. MMWR Morb Mortal Wkly Rep. 1989;38:612-614.
PUBMED
34. Yeoh TS, Lee As, Lee HS. Absorption of mercuric sulphide following oral administration in mice. Toxicology. 1986;41:107-111.
FULL TEXT
|
ISI
| PUBMED
35. D'Arcy PF. Adverse reactions and interactions with herbal medicines, I: adverse reactions. Adverse Drug React Toxicol Rev. 1991;10:189-208.
ISI
| PUBMED
36. Tyler VE. The Honest Herbal. Binghampton, NY: Pharmaceutical Products Press; 1993.
37. Schulz V, Hänsel R, Tyler VE. Rational Phytotherapy: A Physician's Guide to Herbal Medicine. New York, NY: Springer-Verlag NY Inc; 1997.
38. Ridker PM. Toxic effects of herbal teas. Arch Environ Health. 1987;42:133-136.
ISI
| PUBMED
39. Ridker PM. Health hazards of unusual herbal teas. Am Fam Physician. 1989;39:153-156.
ISI
| PUBMED
40. Larrey D, Vial T, Pauwels A, et al. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatoxicity. Ann Intern Med. 1992;117:129-132.
41. Castot A, Larrey D. Hepatitis observed during a treatment with a drug or tea containing wild Germander: evaluation of 26 cases reported to the Regional Centers of Pharmacovigilance. Gastroenterol Clin Biol. 1992;16:916-922.
ISI
| PUBMED
42. Katz M, Saibil F. Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. J Clin Gastroenterol. 1990;12:203-206.
ISI
| PUBMED
43. Clark F, Reed R. Chaparral-induced toxic hepatitis: California and Texas 1992. MMWR Morb Mortal Wkly Rep. 1992;41:812-814.
PUBMED
44. Smith BC, Desmond PV. Acute hepatitis induced by ingestion of the herbal medication chaparral. Aust N Z J Med. 1993;23:526.
ISI
| PUBMED
45. Anderson T, Konracki S, Lyman D, Parkin W. Diarrhea from herbal tea: New York, Pennsylvania. MMWR Morb Mortal Wkly Rep. 1978;27:248-249.
46. Makheja A, Vanderhoek J, Martyn B. Inhibition of platelet aggregation and thromboxane synthesis by onion and garlic. Lancet. 1979;1:781.
47. Siegal RK. Ginseng abuse syndrome. JAMA. 1979;241:1614-1615.
FREE FULL TEXT
48. Perrotta DM, Coody G, Culmo C. Adverse events associated with ephedrine-containing products: Texas, December 1993-September 1995. JAMA. 1996;276:1711-1712.
FREE FULL TEXT
49. Knight TE, Hausen BM. Melaleuca oil (tea tree oil) dermatitis. J Am Acad Dermatol. 1994;30:423-427.
ISI
| PUBMED
50. Itami N, Yamamoto K, Andoh T, Akutsu Y. Herbal medicine can induce hypertension. Nephron. 1991;59:339-340.
ISI
| PUBMED
51. Liu G. Pharmacological actions and clinical use of Fructus Shizandrae. Chin Med J. 1989;102:740-749.
PUBMED
52. Eaton EA, Walle UK, Lewis AJ, Hudson T, Wilson AA, Walle T. Flavonoids, potent inhibitors of the human form phenolsulfotransferase: potential role in drug metabolism and chemoprevention. Drug Metab Dispos. 1996;24:232-237.
ABSTRACT
53. Schubert W, Eriksson U, Edgar B, Cullberg G, Hedner T. Flavonoids in grapefruit juice inhibit the in vitro hepatic metabolism of 17-beta-estradiol. Eur J Drug Metab Pharmacokinet. 1995;20:219-224.
ISI
| PUBMED
54. Cassileth BR. The social implications for questionable cancer therapies. Cancer. 1989;63:1247-1250.
FULL TEXT
|
ISI
| PUBMED
55. Brevoort P. The US botanical market: an overview. HerbalGram. 1996;36:49-57.
56. Houghton PJ. Valerian. Pharm J. 1994;253:95-96.
57. LeBars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. A placebo-controlled, double-blind randomized trial of an extract Ginkgo biloba for dementia. JAMA. 1997;278:1327-1332.
FREE FULL TEXT
58. Gillis CN. Panax ginseng pharmacology: a nitric oxide link? Biochem Pharmacol. 1997;54:1-8.
FULL TEXT
|
ISI
| PUBMED
59. Bach D, Schmitt M, Ebeling L. Phytopharmaceutical and synthetic agents in the treatment of benign prostatic hyperplasia (BPH). Phytomedicine. 1997;4:309-313.
60. Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D. St John's wort for depression: an overview and meta-analysis of randomised clinical trials. BMJ. 1996;313:253-258.
FREE FULL TEXT
61. Bauer VR, Jurcic K, Puhlmann J, Wagner H. Immunologic in vivo and in vitro studies on Echinacea extracts. Arzneimittelforschung. 1988;38:276-281.
PUBMED
62. Mowrey DB, Clayson DE. Motion sickness, ginger, and psychophysics. Lancet. 1982;1:655-657.
ISI
| PUBMED
63. Stewart JJ, Wood MJ, Wood CD, Mims ME. Effects of ginger on motion sickness susceptibility and gastric function. Pharmacology. 1991;42:111-120.
ISI
| PUBMED
64. Knight DW. Feverfew: chemistry and biological activity. Natl Prod Rep. 1995;12:271-276.
65. Cavadas C, Araujo I, Cotrim MD, et al. In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABA-A receptor in rat brain. Arzneimittelforschung. 1995;45:753-755.
66. Holzgartner H, Schmidt U, Kuhn U. Comparison of the efficacy and tolerance of a garlic preparation vs benzfibrate. Arzneimittelforschung. 1992;42:1473-1477.
PUBMED
67. Miller S. A natural mood booster. Newsweek. May 5, 1997:74-75.
68. Duran N, Song PS. Hypericin and its photodynamic action. Photochem Photobiol. 1986;43:677-680.
ISI
| PUBMED
69. Sultan C, Terraza A, Devillier C, et al. Inhibition of androgen metabolism and binding by a liposterolic extract of Serenoa repens B in human foreskin fibroblasts. J Steroid Biochem. 1984;20:515-519.
FULL TEXT
|
ISI
| PUBMED
70. Kessler DA. Introducing MEDWATCH: a new approach to reporting medication and device adverse effects and product problems. JAMA. 1993;269:2765-2768.
FREE FULL TEXT
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The 'Natural Health Service': natural does not mean safe
Dunne
Adv. Psychiatr. Treat. 2009;15:49-56.
ABSTRACT
| FULL TEXT
Herb and Supplement Use Among the Retail Population of an Independent, Urban Herb Store
Archer and Boyle
J Holist Nurs 2008;26:27-35.
ABSTRACT
Nonvitamin, Nonmineral Dietary Supplementation in HIV-Positive People
Sansevero et al.
Nutr Clin Pract 2007;22:679-687.
ABSTRACT
| FULL TEXT
Ginsenoside Re, a Main Phytosterol of Panax ginseng, Activates Cardiac Potassium Channels via a Nongenomic Pathway of Sex Hormones
Furukawa et al.
Mol. Pharmacol. 2006;70:1916-1924.
ABSTRACT
| FULL TEXT
Amphetamine Lacing of an Internet-Marketed Neutraceutical
Nguyen et al.
Mayo Clin Proc. 2006;81:1627-1629.
ABSTRACT
| FULL TEXT
Use of Herbal Remedies by Hispanic Patients: Do They Inform Their Physician?
Howell et al.
J Am Board Fam Med 2006;19:566-578.
ABSTRACT
| FULL TEXT
In Vitro Interactions of Water-Soluble Garlic Components with Human Cytochromes P450
Greenblatt et al.
J. Nutr. 2006;136:806S-809S.
ABSTRACT
| FULL TEXT
Disclosure of Natural Product Use to Primary Care Physicians: A Cross-sectional Survey of Naturopathic Clinic Attendees
Busse et al.
Mayo Clin Proc. 2005;80:616-623.
ABSTRACT
Biopharmaceuticals derived from genetically modified plants
Goldstein and Thomas
QJM 2004;97:705-716.
ABSTRACT
| FULL TEXT
Use of OTC and Herbal Products in Patients with Cardiovascular Disease
Pharand et al.
The Annals of Pharmacotherapy 2003;37:899-904.
ABSTRACT
| FULL TEXT
Ginsenoside variability in American ginseng samples
Yuan et al.
Am. J. Clin. Nutr. 2002;75:600-601.
FULL TEXT
Herbal Therapy in Dermatology
Bedi and Shenefelt
Arch Dermatol 2002;138:232-242.
ABSTRACT
| FULL TEXT
The Prevalence and Predictors of the Use of Alternative Medicine in Presurgical Patients in Five California Hospitals
Leung et al.
Anesth. Analg. 2001;93:1062-1068.
ABSTRACT
| FULL TEXT
Herbal Medicines and Perioperative Care
Ang-Lee et al.
JAMA 2001;286:208-216.
ABSTRACT
| FULL TEXT
Awareness of CAM Among Residents: A Long Way to Go
Murtaza et al.
Arch Intern Med 2001;161:1679-1680.
FULL TEXT
A Review of the Evidence for the Use of Phytoestrogens as a Replacement for Traditional Estrogen Replacement Therapy
Glazier and Bowman
Arch Intern Med 2001;161:1161-1172.
ABSTRACT
| FULL TEXT
Herbal Therapy: What Every Facial Plastic Surgeon Must Know
Pribitkin and Boger
Arch Facial Plast Surg 2001;3:127-132.
ABSTRACT
| FULL TEXT
Dietary Supplement Use: Consumer Characteristics and Interests
Greger
J. Nutr. 2001;131:1339S-1343.
ABSTRACT
| FULL TEXT
Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled
and
BMJ 2001;322:73-73.
ABSTRACT
| FULL TEXT
The Herbal History of Digitalis: Lessons for Alternative Medicine
Ritter et al.
JAMA 2000;283:884-886.
FULL TEXT
St. John's Wort and Antidepressant Drug Interactions in the Elderly
Lantz et al.
J Geriatr Psychiatry Neurol 1999;12:7-10.
ABSTRACT
"Conventional" and "Unconventional" Medicine: Can They Be Integrated?
Dalen
Arch Intern Med 1998;158:2179-2181.
FULL TEXT
|
